| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |